Chelation therapy: Treating gadolinium retention- Dr. Richard Semelka
Listen now
Description
This episode represents the final part of a series of conversations regarding the safety of gadolinium based contrast agents. Here we discuss who is most at risk for retaining gadolinium and how we can effectively get it out of the body using chelation therapy. I am joined by: Dr Richard Semelka - Dr Richard Semelka is a leading expert in Radiology for body MRI and gadolinium toxicity. He has written over 370 peer-reviewed papers and 16 text-books. and is the first doctor to publish on the entity of gadolinium deposition disease. Dr semelka offers clinical medical consultations for individuals experiencing gadolinium toxicity and in this discussion we will be observing practically how this is treated in the clinic. Kate Skardon - A patient advocate, continuing chelation therapy to remove gadolinium from the body following devastating consequences. Her story can be found here:    https://www.youtube.com/watch?v=4aozx... https://www.youtube.com/watch?v=1RvHA... Debbie Lambert- A patient advocate who seeks to raise awareness about Gadolinium Deposition Disease through various mediums, including the links below: https://m.facebook.com/pg/livingwithg... https://twitter.com/lambertdebb Show notes: HOPO Therapeutics- oral chelation http://www.hopotx.com/science/ SAGE- Symptoms Associated with Gadolinium Exposure https://pubs.rsna.org/doi/abs/10.1148/radiol.2021211349
More Episodes
Published 01/31/23
In this episode of the podcast I discuss the potential applications of ChatGPT in healthcare with Dr Harvey Castro. Dr Castro is a physician, healthcare consultant and author, on a mission to increase awareness of digital health and implement new changes in healthcare. He has just released a...
Published 01/31/23
In this episode I raise awareness of the cancer metabolism study that I will be working on alongside Isabella Cooper at the University of Westminster.  This is a self-funded study that requires support from a number of sources. Establishing key partnerships and engaging with an audience who are...
Published 07/13/22